The global Antiretroviral Drug market size was valued at US$ 30.45 billion in 2024 and is projected to reach US$ 42.67 billion by 2030, at a CAGR of 5.8% during the forecast period 2024-2030.
The United States Antiretroviral Drug market size was valued at US$ 10.23 billion in 2024 and is projected to reach US$ 13.98 billion by 2030, at a CAGR of 5.3% during the forecast period 2024-2030.
Antiretroviral Drugs are medications used to treat HIV/AIDS, working to suppress viral replication and prevent the progression of the disease, including various classes such as NRTIs, NNRTIs, and protease inhibitors.
The global Antiretroviral Drug market is growing steadily, driven by expanding access to treatment in developing countries and the development of new, more effective drug combinations. In 2023, the number of people receiving antiretroviral therapy reached 30.5 million globally, with fixed-dose combinations accounting for 65% of prescriptions. The integrase inhibitor class is the fastest-growing segment at 9.5% annually. The market saw a 20% increase in uptake of long-acting injectable antiretrovirals in 2023, reflecting the trend towards improved treatment adherence. Multi-class combination drugs lead with a 70% market share, but single-tablet regimens are growing at 8% annually. North America leads with a 35% market share, while Africa is the fastest-growing region at 7.5% CAGR, driven by increased funding for HIV treatment programs. The industry is focusing on developing novel drug delivery systems, with a 30% increase in R&D investments for implantable long-acting antiretroviral therapies. Generic antiretrovirals now account for 80% of global procurement volumes, contributing to increased treatment access in low- and middle-income countries.
Report Overview
Tire-derived fuel (TDF) is composed of shredded scrap tires.
This report provides a deep insight into the global Antiretroviral Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antiretroviral Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antiretroviral Drug market in any manner.
Global Antiretroviral Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Gilead Sciences
ViiV Healthcare
Bristol-Myer Squibb
AbbVie
Boehringer-Ingelheim
Johnson and Johnson
Merck
CIPLA
Market Segmentation (by Type)
Multi-Class Drugs Combination
NRTI
NNRTI
Protease Inhibitors
Other
Market Segmentation (by Application)
Hospital
Pharmaceutical Companies
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antiretroviral Drug Market
Overview of the regional outlook of the Antiretroviral Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antiretroviral Drug
1.2 Key Market Segments
1.2.1 Antiretroviral Drug Segment by Type
1.2.2 Antiretroviral Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antiretroviral Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Antiretroviral Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antiretroviral Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antiretroviral Drug Market Competitive Landscape
3.1 Global Antiretroviral Drug Sales by Manufacturers (2019-2024)
3.2 Global Antiretroviral Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antiretroviral Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antiretroviral Drug Sales Sites, Area Served, Product Type
3.6 Antiretroviral Drug Market Competitive Situation and Trends
3.6.1 Antiretroviral Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antiretroviral Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antiretroviral Drug Industry Chain Analysis
4.1 Antiretroviral Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antiretroviral Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antiretroviral Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiretroviral Drug Sales Market Share by Type (2019-2024)
6.3 Global Antiretroviral Drug Market Size Market Share by Type (2019-2024)
6.4 Global Antiretroviral Drug Price by Type (2019-2024)
7 Antiretroviral Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiretroviral Drug Market Sales by Application (2019-2024)
7.3 Global Antiretroviral Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Antiretroviral Drug Sales Growth Rate by Application (2019-2024)
8 Antiretroviral Drug Market Segmentation by Region
8.1 Global Antiretroviral Drug Sales by Region
8.1.1 Global Antiretroviral Drug Sales by Region
8.1.2 Global Antiretroviral Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Antiretroviral Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antiretroviral Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antiretroviral Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antiretroviral Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antiretroviral Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Gilead Sciences
9.1.1 Gilead Sciences Antiretroviral Drug Basic Information
9.1.2 Gilead Sciences Antiretroviral Drug Product Overview
9.1.3 Gilead Sciences Antiretroviral Drug Product Market Performance
9.1.4 Gilead Sciences Business Overview
9.1.5 Gilead Sciences Antiretroviral Drug SWOT Analysis
9.1.6 Gilead Sciences Recent Developments
9.2 ViiV Healthcare
9.2.1 ViiV Healthcare Antiretroviral Drug Basic Information
9.2.2 ViiV Healthcare Antiretroviral Drug Product Overview
9.2.3 ViiV Healthcare Antiretroviral Drug Product Market Performance
9.2.4 ViiV Healthcare Business Overview
9.2.5 ViiV Healthcare Antiretroviral Drug SWOT Analysis
9.2.6 ViiV Healthcare Recent Developments
9.3 Bristol-Myer Squibb
9.3.1 Bristol-Myer Squibb Antiretroviral Drug Basic Information
9.3.2 Bristol-Myer Squibb Antiretroviral Drug Product Overview
9.3.3 Bristol-Myer Squibb Antiretroviral Drug Product Market Performance
9.3.4 Bristol-Myer Squibb Antiretroviral Drug SWOT Analysis
9.3.5 Bristol-Myer Squibb Business Overview
9.3.6 Bristol-Myer Squibb Recent Developments
9.4 AbbVie
9.4.1 AbbVie Antiretroviral Drug Basic Information
9.4.2 AbbVie Antiretroviral Drug Product Overview
9.4.3 AbbVie Antiretroviral Drug Product Market Performance
9.4.4 AbbVie Business Overview
9.4.5 AbbVie Recent Developments
9.5 Boehringer-Ingelheim
9.5.1 Boehringer-Ingelheim Antiretroviral Drug Basic Information
9.5.2 Boehringer-Ingelheim Antiretroviral Drug Product Overview
9.5.3 Boehringer-Ingelheim Antiretroviral Drug Product Market Performance
9.5.4 Boehringer-Ingelheim Business Overview
9.5.5 Boehringer-Ingelheim Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Antiretroviral Drug Basic Information
9.6.2 Johnson and Johnson Antiretroviral Drug Product Overview
9.6.3 Johnson and Johnson Antiretroviral Drug Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Merck
9.7.1 Merck Antiretroviral Drug Basic Information
9.7.2 Merck Antiretroviral Drug Product Overview
9.7.3 Merck Antiretroviral Drug Product Market Performance
9.7.4 Merck Business Overview
9.7.5 Merck Recent Developments
9.8 CIPLA
9.8.1 CIPLA Antiretroviral Drug Basic Information
9.8.2 CIPLA Antiretroviral Drug Product Overview
9.8.3 CIPLA Antiretroviral Drug Product Market Performance
9.8.4 CIPLA Business Overview
9.8.5 CIPLA Recent Developments
10 Antiretroviral Drug Market Forecast by Region
10.1 Global Antiretroviral Drug Market Size Forecast
10.2 Global Antiretroviral Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antiretroviral Drug Market Size Forecast by Country
10.2.3 Asia Pacific Antiretroviral Drug Market Size Forecast by Region
10.2.4 South America Antiretroviral Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antiretroviral Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Antiretroviral Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antiretroviral Drug by Type (2025-2030)
11.1.2 Global Antiretroviral Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antiretroviral Drug by Type (2025-2030)
11.2 Global Antiretroviral Drug Market Forecast by Application (2025-2030)
11.2.1 Global Antiretroviral Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Antiretroviral Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antiretroviral Drug Market Size Comparison by Region (M USD)
Table 5. Global Antiretroviral Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antiretroviral Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antiretroviral Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antiretroviral Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Drug as of 2022)
Table 10. Global Market Antiretroviral Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antiretroviral Drug Sales Sites and Area Served
Table 12. Manufacturers Antiretroviral Drug Product Type
Table 13. Global Antiretroviral Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antiretroviral Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiretroviral Drug Market Challenges
Table 22. Global Antiretroviral Drug Sales by Type (Kilotons)
Table 23. Global Antiretroviral Drug Market Size by Type (M USD)
Table 24. Global Antiretroviral Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antiretroviral Drug Sales Market Share by Type (2019-2024)
Table 26. Global Antiretroviral Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Antiretroviral Drug Market Size Share by Type (2019-2024)
Table 28. Global Antiretroviral Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antiretroviral Drug Sales (Kilotons) by Application
Table 30. Global Antiretroviral Drug Market Size by Application
Table 31. Global Antiretroviral Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antiretroviral Drug Sales Market Share by Application (2019-2024)
Table 33. Global Antiretroviral Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Antiretroviral Drug Market Share by Application (2019-2024)
Table 35. Global Antiretroviral Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Antiretroviral Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antiretroviral Drug Sales Market Share by Region (2019-2024)
Table 38. North America Antiretroviral Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antiretroviral Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antiretroviral Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antiretroviral Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antiretroviral Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Gilead Sciences Antiretroviral Drug Basic Information
Table 44. Gilead Sciences Antiretroviral Drug Product Overview
Table 45. Gilead Sciences Antiretroviral Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Gilead Sciences Business Overview
Table 47. Gilead Sciences Antiretroviral Drug SWOT Analysis
Table 48. Gilead Sciences Recent Developments
Table 49. ViiV Healthcare Antiretroviral Drug Basic Information
Table 50. ViiV Healthcare Antiretroviral Drug Product Overview
Table 51. ViiV Healthcare Antiretroviral Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. ViiV Healthcare Business Overview
Table 53. ViiV Healthcare Antiretroviral Drug SWOT Analysis
Table 54. ViiV Healthcare Recent Developments
Table 55. Bristol-Myer Squibb Antiretroviral Drug Basic Information
Table 56. Bristol-Myer Squibb Antiretroviral Drug Product Overview
Table 57. Bristol-Myer Squibb Antiretroviral Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bristol-Myer Squibb Antiretroviral Drug SWOT Analysis
Table 59. Bristol-Myer Squibb Business Overview
Table 60. Bristol-Myer Squibb Recent Developments
Table 61. AbbVie Antiretroviral Drug Basic Information
Table 62. AbbVie Antiretroviral Drug Product Overview
Table 63. AbbVie Antiretroviral Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AbbVie Business Overview
Table 65. AbbVie Recent Developments
Table 66. Boehringer-Ingelheim Antiretroviral Drug Basic Information
Table 67. Boehringer-Ingelheim Antiretroviral Drug Product Overview
Table 68. Boehringer-Ingelheim Antiretroviral Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Boehringer-Ingelheim Business Overview
Table 70. Boehringer-Ingelheim Recent Developments
Table 71. Johnson and Johnson Antiretroviral Drug Basic Information
Table 72. Johnson and Johnson Antiretroviral Drug Product Overview
Table 73. Johnson and Johnson Antiretroviral Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Johnson and Johnson Business Overview
Table 75. Johnson and Johnson Recent Developments
Table 76. Merck Antiretroviral Drug Basic Information
Table 77. Merck Antiretroviral Drug Product Overview
Table 78. Merck Antiretroviral Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Merck Business Overview
Table 80. Merck Recent Developments
Table 81. CIPLA Antiretroviral Drug Basic Information
Table 82. CIPLA Antiretroviral Drug Product Overview
Table 83. CIPLA Antiretroviral Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CIPLA Business Overview
Table 85. CIPLA Recent Developments
Table 86. Global Antiretroviral Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Antiretroviral Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Antiretroviral Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Antiretroviral Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Antiretroviral Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Antiretroviral Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Antiretroviral Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Antiretroviral Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Antiretroviral Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Antiretroviral Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Antiretroviral Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Antiretroviral Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Antiretroviral Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Antiretroviral Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Antiretroviral Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Antiretroviral Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Antiretroviral Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Antiretroviral Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiretroviral Drug Market Size (M USD), 2019-2030
Figure 5. Global Antiretroviral Drug Market Size (M USD) (2019-2030)
Figure 6. Global Antiretroviral Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiretroviral Drug Market Size by Country (M USD)
Figure 11. Antiretroviral Drug Sales Share by Manufacturers in 2023
Figure 12. Global Antiretroviral Drug Revenue Share by Manufacturers in 2023
Figure 13. Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antiretroviral Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antiretroviral Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antiretroviral Drug Market Share by Type
Figure 18. Sales Market Share of Antiretroviral Drug by Type (2019-2024)
Figure 19. Sales Market Share of Antiretroviral Drug by Type in 2023
Figure 20. Market Size Share of Antiretroviral Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Antiretroviral Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antiretroviral Drug Market Share by Application
Figure 24. Global Antiretroviral Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Antiretroviral Drug Sales Market Share by Application in 2023
Figure 26. Global Antiretroviral Drug Market Share by Application (2019-2024)
Figure 27. Global Antiretroviral Drug Market Share by Application in 2023
Figure 28. Global Antiretroviral Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antiretroviral Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antiretroviral Drug Sales Market Share by Country in 2023
Figure 32. U.S. Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antiretroviral Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antiretroviral Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antiretroviral Drug Sales Market Share by Country in 2023
Figure 37. Germany Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antiretroviral Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antiretroviral Drug Sales Market Share by Region in 2023
Figure 44. China Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antiretroviral Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Antiretroviral Drug Sales Market Share by Country in 2023
Figure 51. Brazil Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antiretroviral Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antiretroviral Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antiretroviral Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antiretroviral Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antiretroviral Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antiretroviral Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antiretroviral Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Antiretroviral Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Antiretroviral Drug Market Share Forecast by Application (2025-2030)
